Valuation: genOway

Market Cap 22.59M 26.15M 21.25M 19.32M 36.33M 2.51B 36.86M 249M 97.7M 1.25B 98.2M 96.06M 4.17B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.31M 33.93M 27.57M 25.06M 47.14M 3.25B 47.83M 323M 127M 1.63B 127M 125M 5.42B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 week-2.00%
Current month+0.41%
1 month-4.67%
3 months+1.24%
6 months+1.24%
Current year-9.59%
1 week 2.43
Extreme 2.43
2.5
1 month 2.4
Extreme 2.4
2.58
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 28/02/1999
Director of Finance/CFO - 30/09/2015
Director TitleAgeSince
Director/Board Member - 28/02/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.00%-20.45%-32.13% 26.17M
-0.11%-1.67%+1.80%+19.90% 48.84B
+1.89%+5.08%+492.59%+629.24% 45.44B
+1.83%+2.75%+15.61%+91.22% 41.22B
-0.50%-1.56%+24.67%+12.17% 39.71B
-2.74%-7.13%+18.72%+49.04% 32.6B
-1.14%-2.51%+27.52%+136.42% 16.67B
+0.59%-2.25% - - 16.25B
-0.49%-0.34%+3.45%+29.14% 14.08B
-2.60%-1.00%+77.85%+40.37% 13.68B
Average -0.33%-1.00%+71.31%+108.37% 26.85B
Weighted average by Cap. -0.02%-0.41%+104.16%+153.18%

Financials

2024 2025
Net sales 27.53M 31.88M 25.9M 23.54M 44.28M 3.05B 44.93M 304M 119M 1.53B 120M 117M 5.09B 28.6M 33.11M 26.91M 24.46M 46M 3.17B 46.67M 316M 124M 1.59B 124M 122M 5.29B
Net income 1.83M 2.12M 1.72M 1.57M 2.94M 203M 2.99M 20.21M 7.92M 102M 7.96M 7.79M 338M 928K 1.07M 873K 793K 1.49M 103M 1.51M 10.24M 4.01M 51.47M 4.03M 3.95M 171M
Net Debt 623K 721K 586K 533K 1M 69.11M 1.02M 6.88M 2.69M 34.56M 2.71M 2.65M 115M 6.72M 7.78M 6.32M 5.74M 10.81M 745M 10.96M 74.15M 29.06M 373M 29.2M 28.57M 1.24B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
18/08/26 €2.450 0.00% 805
17/08/26 €2.450 -1.21% 500
14/08/26 €2.480 0.00% 2,115
13/08/26 €2.480 -1.59% 5,147
12/08/26 €2.520 +0.80% 20,564
  1. Stock Market
  2. Stocks
  3. ALGEN Stock